
Chief Executive Officer
Introducing Thushara Vajera Perera, the newly appointed CEO of SLINTEC, marking a momentous occasion for the organization. His exceptional aptitude for bridging the gap between fundamental research, product development, and successful commercialization heralds the dawn of a remarkable era of innovation at SLINTEC. Thushara’s illustrious career boasts influential roles as a senior scientist at esteemed institutions such as Celera Genomics, Amgen, and Pfizer. Moreover, his comprehensive studies and training at the prestigious Harvard University have honed his skills and bestowed him with invaluable knowledge, empowering him to steer SLINTEC towards unprecedented growth. With open arms, we extend a warm welcome to Thushara Vajera Perera, eagerly anticipating the exhilarating journey that lies ahead.